Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1121

1.

Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States.

Riedl MA, Banerji A, Busse PJ, Johnston DT, Davis-Lorton MA, Patel S, Parr H, Chiao J, Watson DJ, Burrell E, Machnig T.

Ann Allergy Asthma Immunol. 2017 Jul;119(1):59-64. doi: 10.1016/j.anai.2017.05.017.

PMID:
28668241
2.

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.

Longhurst H, Cicardi M, Craig T, Bork K, Grattan C, Baker J, Li HH, Reshef A, Bonner J, Bernstein JA, Anderson J, Lumry WR, Farkas H, Katelaris CH, Sussman GL, Jacobs J, Riedl M, Manning ME, Hebert J, Keith PK, Kivity S, Neri S, Levy DS, Baeza ML, Nathan R, Schwartz LB, Caballero T, Yang W, Crisan I, Hernandez MD, Hussain I, Tarzi M, Ritchie B, Králíčková P, Guilarte M, Rehman SM, Banerji A, Gower RG, Bensen-Kennedy D, Edelman J, Feuersenger H, Lawo JP, Machnig T, Pawaskar D, Pragst I, Zuraw BL; COMPACT Investigators.

N Engl J Med. 2017 Mar 23;376(12):1131-1140. doi: 10.1056/NEJMoa1613627.

PMID:
28328347
3.

Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.

Bernstein JA, Relan A, Harper JR, Riedl M.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):452-455. doi: 10.1016/j.anai.2017.01.029. Epub 2017 Mar 9.

4.

Anabolic androgen use in the management of hereditary angioedema: Not so cheap after all.

Tse KY, Zuraw BL, Chen Q, Christiansen SC.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):456-460.e1. doi: 10.1016/j.anai.2017.01.015. Epub 2017 Mar 7.

PMID:
28283277
5.

Kallikrein Inhibition for Hereditary Angioedema.

Longhurst HJ.

N Engl J Med. 2017 Feb 23;376(8):788-789. doi: 10.1056/NEJMe1611929. No abstract available.

PMID:
28225685
6.

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis.

Banerji A, Busse P, Shennak M, Lumry W, Davis-Lorton M, Wedner HJ, Jacobs J, Baker J, Bernstein JA, Lockey R, Li HH, Craig T, Cicardi M, Riedl M, Al-Ghazawi A, Soo C, Iarrobino R, Sexton DJ, TenHoor C, Kenniston JA, Faucette R, Still JG, Kushner H, Mensah R, Stevens C, Biedenkapp JC, Chyung Y, Adelman B.

N Engl J Med. 2017 Feb 23;376(8):717-728. doi: 10.1056/NEJMoa1605767.

PMID:
28225674
7.

Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study.

Triggianese P, Guarino MD, Pellicano C, Borzi M, Greco E, Modica S, De Carolis C, Perricone R.

Int Arch Allergy Immunol. 2017;172(1):55-63. doi: 10.1159/000453663. Epub 2017 Feb 22.

PMID:
28222436
8.

Mutational spectrum of the SERPING1 gene in Swiss patients with hereditary angioedema.

Steiner UC, Keller M, Schmid P, Cichon S, Wuillemin WA.

Clin Exp Immunol. 2017 Jun;188(3):430-436. doi: 10.1111/cei.12941. Epub 2017 Mar 19.

PMID:
28194776
9.

Screening for hereditary angioedema (HAE) at 13 emergency centers in Osaka, Japan: A prospective observational study.

Hirose T, Kimbara F, Shinozaki M, Mizushima Y, Yamamoto H, Kishi M, Kiguchi T, Shiono S, Noborio M, Fuke A, Akimoto H, Kimura T, Kaga S, Horiuchi T, Shimazu T.

Medicine (Baltimore). 2017 Feb;96(6):e6109. doi: 10.1097/MD.0000000000006109.

10.

Hereditary Angioedema: Implications of Management.

Pathria M, Krishnaswamy G, Guarderas JC.

South Med J. 2017 Feb;110(2):101-106. doi: 10.14423/SMJ.0000000000000604. Review.

PMID:
28158879
11.

[Angioedema and the role of bradykinins: new treatments and implications in patients with heart failure].

Mansi M, Wu MA, Zanichelli A, Cicardi M.

G Ital Cardiol (Rome). 2016 Dec;17(12):966-972. doi: 10.1714/2612.26889. Italian.

PMID:
28151501
12.

Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase.

Weller K, Maurer M, Fridman M, Supina D, Schranz J, Magerl M.

Allergy Asthma Proc. 2017 Mar 16;38(2):143-151. doi: 10.2500/aap.2017.38.4025. Epub 2017 Jan 16.

PMID:
28093999
13.

Novel usage of fresh frozen plasma in hereditary angioedema.

Hanizah N, Affirul CA, Farah NA, Shamila MA, Ridzuan MI.

Clin Ter. 2016 Nov-Dec;167(6):182-184. doi: 10.7417/CT.2016.1969.

PMID:
28051822
14.

Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency.

Frank MM, Zuraw B, Banerji A, Bernstein JA, Craig T, Busse P, Christiansen S, Davis-Lorton M, Li HH, Lumry WR, Riedl M; US Hereditary Angioedema Association Medical Advisory Board.

Pediatrics. 2016 Nov;138(5). pii: e20160575.

PMID:
27940765
15.

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.

Longhurst HJ, Zanichelli A, Caballero T, Bouillet L, Aberer W, Maurer M, Fain O, Fabien V, Andresen I; IOS Study Group.

Clin Exp Immunol. 2017 Apr;188(1):148-153. doi: 10.1111/cei.12910. Epub 2017 Feb 9.

16.

Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema.

Riedl MA, Lumry WR, Li HH, Banerji A, Bernstein JA, Ba M, Bjrkander J, Magerl M, Maurer M, Rockich K, Chen H, Schranz J.

Allergy Asthma Proc. 2016 Nov;37(6):489-500.

PMID:
27931305
17.

Hereditary angioedema (HAE): a cause for recurrent abdominal pain.

Soni P, Kumar V, Alliu S, Shetty V.

BMJ Case Rep. 2016 Nov 14;2016. pii: bcr2016217196. doi: 10.1136/bcr-2016-217196.

PMID:
27873761
18.

Hereditary angioedema with F12 mutation: Clinical features and enzyme polymorphisms in 9 Southwestern Spanish families.

Piñero-Saavedra M, González-Quevedo T, Saenz de San Pedro B, Alcaraz C, Bobadilla-González P, Fernández-Vieira L, Hinojosa B, García-Lozano R.

Ann Allergy Asthma Immunol. 2016 Nov;117(5):520-526. doi: 10.1016/j.anai.2016.09.001. Epub 2016 Oct 24.

PMID:
27788882
19.

Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.

Farkas H, Varga L, Moldovan D, Obtulowicz K, Shirov T, Machnig T, Feuersenger H, Edelman J, Williams-Herman D, Rojavin M.

Ann Allergy Asthma Immunol. 2016 Nov;117(5):508-513. doi: 10.1016/j.anai.2016.08.025. Epub 2016 Oct 24.

20.

Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting.

Zanichelli A, Longhurst HJ, Maurer M, Bouillet L, Aberer W, Fabien V, Andresen I, Caballero T; IOS Study Group.

Ann Allergy Asthma Immunol. 2016 Oct;117(4):394-398. doi: 10.1016/j.anai.2016.08.014.

Supplemental Content

Loading ...
Support Center